736 , Shakti Khund III , New Delhi
+1778-732-2562

Global Pharmaceutical Drugs Market By Type(Oral Drug Delivery, Ocular Drug Delivery, others), By Application (Cancer, Diabetics, Others), By End User (Hospitals, Home Care, Others), By Region–Forecast & Opportunities to 2026

Report Description

The pharmaceutical drug market accounted for USD 1,403.1 billion in 2019. It is projected to register growth at CAGR of 2.9% during the forecast period.

COVID-19 has impacted all the businesses across the globe. Corona virus has captured 215 countries and territories till now. Due to corona virus the market share of infectious disease segment has been increased. COVID-19 has given a boost to pharmaceutical drug delivery market during the forecast period. Corona virus has been increasing exponentially, all the hospitals giving extra care to COVID-19 patience and added immunity support. Due to this the adoption of drugs such as multivitamin, vitamin C, antiviral and many others has been increased. Thus the pharmaceutical market is expected to witness growth during forecast period.

Definition:

The pharmaceutical drugs delivery systems are formulation of drugs which are responsible for controlling the administration of medication with the help of chemical trigger. The pharmaceutical drug delivery improves safety and efficacy of pharmaceutical drug by controlling the site of release of drug, time and rate.

Market Dynamics (Drivers/Opportunities):

The rise in expenditure in healthcare by government and private agencies are driving the pharmaceutical drug delivery market. Government is also investing in research in drug delivery market. Some of the private agencies are also investing for research in pharmaceutical drug delivery market. This factor is likely to drive growth in this sector during forecast period.

The rise in number of chronic disease cases such as cancer, diabetics, respiratory diseases and cardiovascular diseases etc requires use of pharmaceutical drug delivery systems. This is the major factor driving pharmaceutical drug delivery market worldwide.

The technological advancement in the pharmaceutical industry has lead to new product launches worldwide. The corona virus outbreak has also caused sudden growth in pharmaceutical drug delivery market. The rising demand for biosimilars is also a market driver. The growth in biologics market is also contributing immensely in pharmaceutical drug delivery market. It is estimated that biologics market will contribute XX% of the sales of pharmaceuticals companies by 2026.

Market Insights, by Type

Based on the route of administration the pharmaceutical drug delivery market is segmented into oral drug delivery, injectable oral drug delivery systems, topical drug delivery system, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery and implantable drug delivery. The injectable drug delivery system accounted for maximum market share in 2019.

Topical drug delivery system is projected to register growth at highest CAGR during the forecast period. Topical drug delivery system is easy and convenient to use. It has some merits such as plain less and noninvasive delivery, enhanced patient compliance and right dosage to the right place. These merits are responsible for attributing growth in pharmaceutical drug delivery market.

Market Insights, by Application

Based on application the pharmaceutical drug delivery market is segmented into cancer, infectious disease, diabetics, respiratory disease, central nervous system disorders, cardiovascular disease, autoimmune diseases and others. The cancer segment has accounted for maximum market share in 2019. The large number cancer cases worldwide had driven this segment towards growth.

The infectious disease segment is projected to register growth at highest CAGR during the forecast period. The rising number infectious disease across all regions is driving the growth in this segment.

Market Insights, by End-User

Based on facility of use the pharmaceutical drug delivery market segmented into hospitals, ambulatory surgery clinics, home care settings, diagnostic centers and others. The hospital segment has accounted for maximum market share in 2019. The large number of inpatient and outpatient visits and availability of all the facility had driven this market towards growth. The home care setting segments is estimated to register growth at highest CAGR during the forecast period.

Regional Insights

North America accounted for XX% market share which is highest in 2019. The technological advancement in pharmaceuticals industry drives the market growth in North America region. The rising number of chronic disease cases and growth in biologics are other driving factors for Pharmaceutical drugs delivery market growth.

The North America region is expected to register growth at highest CAGR during the forecast period. The rising number of chronic disease cases is likely to be the major driving factor. The easy availability of drugs delivery system also drives the market.

Key Companies & Market Share Insights

The Key market players in Pharmaceutical drug delivery are Merck & Co., Johnson & Johnson, F. Hoffman-la Roche, Bayer AG, Novartis AG, Pfizer Inc., 3M Company, Becton, GlaxoSmithkline Plc, Dickinson & Company, Sanofi and Antares Pharma.

Segments Covered in the Report

This report forecasts The Global Pharmaceutical Drug Delivery Market, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2026. For the purpose of this study, Our Company has segmented the global pharmaceutical drug delivery market report on the basis of type, application, and end-user.

Pharmaceutical drug delivery Market Size & Forecast (2017-2026)

  1. Research Framework
    • Market Definition and Product Overview
    • Market Segmentation
  2. Research Methodology
    • Qualitative Research
      • Primary & Secondary Sources
    • Quantitative Research
      • Primary & Secondary Sources
    • Breakdown of Primary Research Respondents, By Region
      • Secondary Research
      • Primary Research
    • Breakdown of Primary Research Respondents, By Industry Participants
      • Market Size Estimation
      • Assumption for the Study
      • Market Breakdown & Data Triangulation
  3. Executive Summary
    • Market Snapshot
  4. Industry Insights
    • Industry ecosystem analysis
      • ValueChain Analysis
    • Industry impact and forces
      • Growth Drivers
      • Challenges &Restraints
      • Opportunities
    • Disruptive Technological Analysis
    • Regulatory framework
      • North America
      • Europe
      • Asia Pacific
      • Middle East & Africa
      • South America
    • Growth potential analysis, 2019
    • Porter’s Five forces analysis
    • Pricing Analysis
      • North America
      • Europe
      • Asia Pacific
      • Middle East & Africa
      • South America
  1. COVID – Impact Analysis
    • North America
    • Europe
    • Asia Pacific
    • Middle East & Africa
    • South America
  2. Pharmaceutical drug delivery Market, By Type, Market Size & Forecast To 2026

(USD Million 2017,2018, 2019, 2020, 2021-e-2026-p)

  • Introduction
  • Oral Drug Delivery
  • Injectable Oral Drug Delivery Systems
  • Topical Drug Delivery System
  • Ocular Drug Delivery
  • Pulmonary Drug Delivery
  • Nasal Drug Delivery
  • Transmucosal Drug Delivery
  • Implantable Drug Delivery
  1. Pharmaceutical drug delivery Market, By Application, Market Size & Forecast To 2026

(USD Million 2017,2018, 2019, 2020, 2021-e-2026-p)

  • Introduction
  • Cancer
  • Infectious Disease
  • Diabetics
  • Respiratory Disease
  • Central Nervous System Disorders
  • Cardiovascular Disease
  • Autoimmune Diseases
  • Others
  1. Pharmaceutical drug delivery Market, By End User, Market Size & Forecast To 2026

(USD Million 2017,2018, 2019, 2020, 2021-e-2026-p)

  • Introduction
  • Hospitals
  • Ambulatory Surgery Clinics
  • Home Care Settings
  • Diagnostic Centers
  • Others
  1. Pharmaceutical drug delivery Market, By Region, Market Size & Forecast To 2026

(USD Million 2017,2018, 2019, 2020, 2021-e-2026-p)

  • Introduction
  • North America Market Size & Forecast To 2026
    • Market Overview
    • COVID-19 Impact
    • By Type
    • By Application
    • By End-User
    • By Country
      • USA
        • By End-User
      • Canada
      • Mexico
    • South America Market Size & Forecast To 2026
      • Market Overview
      • COVID-19 Impact
      • By Type
      • By Application
      • By End-User
      • By Country
        • Brazil
          • By End-User
        • Argentina
        • Chile
        • Rest of South America
      • Europe Market Size & Forecast To 2026
        • Market Overview
        • COVID-19 Impact
        • By Type
        • By Application
        • By End-User
        • By Country
          • UK
            • By End-User
          • Germany
          • France
          • Italy
          • Rest of Europe
        • APAC Market Size & Forecast To 2026
          • Market Overview
          • COVID-19 Impact
          • By Type
          • By Application
          • By End-User
          • By Country
            • China
              • By End-User
            • India
            • Japan
            • South Korea
            • Australia
            • Rest of APAC
          • Middle East & Africa Market Size & Forecast To 2026
            • Market Overview
            • COVID-19 Impact
            • By Type
            • By Application
            • By End-User
            • By Country
              • Saudi Arabia
                • By End-User
              • UAE
              • Qatar
              • Kuwait
              • South Africa
              • Rest of Middle East & Africa
  1. Competitive Landscaping
    • Competitive Benchmarking
      • Market Share Analysis, 2019
      • Global Presence and Growth Strategies
        • Mergers & Acquisitions
        • New Product Launches
        • Investments Trends
        • R&D Initiatives
  1. Company Profile
    • Antares Pharma.
      • Company Overview
      • Financial Overview
      • Product Portfolio
      • Recent Developments
      • SWOT Analysis
      • Strategic Outlook
    • Merck & Co.
    • Johnson & Johnson
    • Hoffman-la Roche
    • Bayer AG
    • Novartis AG
    • Pfizer Inc.
    • 3M Company
    • Becton
    • GlaxoSmithkline Plc
    • Dickinson & Company
    • Sanofi
  2. Appendix
    • Interrelated Market

 

 

Research Methodology

1.1     Research Methodology

The process of market research at PAN Market Consulting is very intuitive being iterative in nature and usually follows the path where Information gathered from secondary research is used to build data models, which are than validated from primary participants. Then same cycle repeats where, according to inputs from primary participants, additional secondary research is done, and new information type is again incorporated into data model. The process continues till desired level of information is not generated.

To calculate the market size, the report considers the revenue generated from the sales of the product/services. The revenue generated from the sales of product/services has been calculated through primary and secondary research. The report also analyses the key players operating in the market at the global level which are identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes product segmentation determined using secondary sources and verified through primary sources.

1.2     Secondary Research

The secondary research source that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • Internal and external proprietary databases, relevant patent and regulatory databases
  • National government documents, statistical databases and market reports
  • News articles, press releases and web-casts specific to the companies operating in the market

The source for secondary research includes but is not limited to Factiva, Hoovers and Statista

SecondaryResearch

1.3     Primary Research

We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following end users:

  • It provides first-hand information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
  • Helps in validating and strengthening the secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/ product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
  • Key opinion leaders specializing in different areas corresponding to different industry end users

1.4     Models

Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data products to produce estimates:

  • Demographic data: Population split by segment
  • Macro-economic indicators: GDP, etc.
  • Industry indicators: Expenditure, product stage & infrastructure, sector growth and facilities.

Data is then cross checked by the expert panel.

1.4.1 Company Share Analysis Model

Company share analysis is used to derive the size of global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps:

ResearchMethodology1

1.4.2 Revenue Based Modeling

Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach whereas it acts as starting point for top-down approach.

ResearchMethodology2

    Buy Now

    Why Choose Us

    • 24*7 Post Sales Support
    • Speak to Analyst for Presentations
    • 15% Free Customization
    • Global, Regional & Country level reports
    • Special Discounts for Startups & Educational Institutions

    Questions ?

    • What is 15% Free Customization?
    • What is Report Subscription?
    • What is the Delivery Time of the Report?

    What You Get

    Data Excel Sheets

    Report in PDF

    Report Subscription

    Analyst Support

    What's Included

    Market Intelligence

    Competitive Intelligence

    Opportunities and Challenges

    Strategic Recommendations